AxoGen (AXGN) Short Interest Ratio & Short Volume $18.80 0.00 (0.00%) As of 12:38 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AxoGen Short Interest DataAxoGen (AXGN) has a short interest of 1.51 million shares, representing 3.69% of the float (the number of shares available for trading by the public). This marks a -18.38% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.8, indicating that it would take 2.8 days of the average trading volume of 404,135 shares to cover all short positions.Current Short Interest1,510,000 sharesPrevious Short Interest1,850,000 sharesChange Vs. Previous Month-18.38%Dollar Volume Sold Short$26.05 millionShort Interest Ratio2.8 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares44,344,000 sharesShort Percent of Float3.69%Today's Trading Volume331,543 sharesAverage Trading Volume404,135 sharesToday's Volume Vs. Average82% Short Selling AxoGen? Sign up to receive the latest short interest report for AxoGen and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAXGN Short Interest Over TimeAXGN Days to Cover Over TimeAXGN Percentage of Float Shorted Over Time Remove Ads AxoGen Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20251,510,000 shares $26.05 million -18.4%3.7%2.8 $17.25 2/28/20251,850,000 shares $37.02 million No Change4.5%3.8 $20.01 2/15/20251,850,000 shares $33.54 million -1.1%4.5%4.3 $18.13 1/31/20251,870,000 shares $34.05 million +50.8%N/A4.5 $18.21 1/15/20251,240,000 shares $23.23 million +20.4%N/A2.9 $18.73 12/31/20241,030,000 shares $16.97 million +2.0%N/A2.7 $16.48 12/15/20241,010,000 shares $14.30 million -7.3%N/A2.8 $14.16 11/30/20241,090,000 shares $15.15 million +3.8%N/A2.9 $13.90 11/15/20241,050,000 shares $13.27 million -7.1%N/A2.6 $12.64 10/31/20241,130,000 shares $15.82 million -8.1%N/A2.6 $14.00 Get the Latest News and Ratings for AXGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AxoGen and its competitors with MarketBeat's FREE daily newsletter. 10/15/20241,230,000 shares $17.65 million +1.7%N/A2.7 $14.35 9/30/20241,210,000 shares $16.96 million -25.8%N/A2.8 $14.02 9/15/20241,630,000 shares $22.48 million -17.7%N/A3.6 $13.79 8/31/20241,980,000 shares $26.04 million +10.0%N/A4.6 $13.15 8/15/20241,800,000 shares $19.84 million -8.2%N/A4.1 $11.02 7/31/20241,960,000 shares $17.21 million -19.7%N/A5.1 $8.78 7/15/20242,440,000 shares $21.13 million +13.5%N/A7.4 $8.66 6/30/20242,150,000 shares $15.57 million +12.0%N/A6.7 $7.24 6/15/20241,920,000 shares $14.67 million +8.5%N/A6 $7.64 5/31/20241,770,000 shares $12.09 million -4.8%N/A6 $6.83 5/15/20241,860,000 shares $11.07 million +2.2%4.6%5.7 $5.95 4/30/20241,820,000 shares $11.67 million +9.0%N/A4.9 $6.41 4/15/20241,670,000 shares $11.74 million -3.5%4.1%4.3 $7.03 3/31/20241,730,000 shares $13.96 million +1.8%4.3%3.9 $8.07 3/15/20241,700,000 shares $13.06 million +21.4%4.2%4 $7.68 2/29/20241,400,000 shares $14.78 million No Change3.4%3 $10.56 2/15/20241,400,000 shares $14.69 million +1.5%3.5%3.1 $10.49 1/31/20241,380,000 shares $13.34 million -2.1%3.4%2.7 $9.67 1/15/20241,410,000 shares $11.14 million -37.9%3.5%2.6 $7.90 12/31/20232,270,000 shares $15.50 million +7.1%5.6%4.1 $6.83 12/15/20232,120,000 shares $15.45 million -20.6%5.2%4.2 $7.29 11/30/20232,670,000 shares $17.49 million +23.6%6.6%5.6 $6.55 11/15/20232,160,000 shares $12.44 million +33.3%5.3%5 $5.76 10/31/20231,620,000 shares $6.09 million +8.7%4.0%4.2 $3.76 10/15/20231,490,000 shares $5.93 million -0.7%3.7%3.8 $3.98 9/30/20231,500,000 shares $7.50 million +6.4%3.8%4.7 $5.00 9/15/20231,410,000 shares $7.68 million No Change3.6%4.8 $5.45 8/31/20231,410,000 shares $8.83 million +21.6%3.6%5.1 $6.26 8/15/20231,160,000 shares $7.15 million +82.7%2.9%4.5 $6.16 7/31/2023635,100 shares $5.49 million +4.3%1.6%2.7 $8.64Musk’s real agenda in D.C. (Ad)In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…Here’s the full story. 7/15/2023608,900 shares $5.37 million -9.2%1.5%3.6 $8.82 6/30/2023670,200 shares $6.12 million -17.4%1.7%4 $9.13 6/15/2023811,800 shares $7.79 million -1.2%2.0%4.8 $9.59 5/31/2023821,300 shares $6.98 million +3.1%2.0%4 $8.50 5/15/2023796,800 shares $7.35 million -4.8%2.0%3.7 $9.23 4/30/2023836,800 shares $7.55 million -24.6%2.1%3.7 $9.02 4/15/20231,110,000 shares $11.11 million -19.0%2.8%4.7 $10.01 3/31/20231,370,000 shares $12.95 million +0.7%3.4%5.6 $9.45 3/15/20231,360,000 shares $11.42 million +19.3%3.4%5.7 $8.40 2/28/20231,140,000 shares $9.41 million +76.3%2.8%5.9 $8.25 2/15/2023646,500 shares $5.82 million +22.0%1.6%3.1 $9.01 1/31/2023530,100 shares $5.02 million +9.8%1.3%2.4 $9.47 1/15/2023482,800 shares $5.13 million -11.2%1.2%2.3 $10.62 12/30/2022543,600 shares $5.43 million +2.1%1.4%2.7 $9.98 12/15/2022532,300 shares $5.70 million +1.6%1.3%2.4 $10.71 11/30/2022524,100 shares $5.74 million -3.4%1.3%2.2 $10.95 11/15/2022542,500 shares $6.58 million -35.1%1.4%2.4 $12.13 10/31/2022836,200 shares $9.55 million -13.2%2.1%4 $11.42 10/15/2022963,300 shares $10.83 million -9.1%2.4%4.5 $11.24 9/30/20221,060,000 shares $12.64 million +29.5%2.6%4.9 $11.92 9/15/2022818,300 shares $9.61 million +5.8%2.0%4.1 $11.74 8/31/2022773,800 shares $7.25 million -4.0%1.9%3.8 $9.37 8/15/2022806,300 shares $9.00 million -0.3%2.0%3.4 $11.16 7/31/2022808,800 shares $7.54 million -17.0%2.0%2.7 $9.32 7/15/2022974,800 shares $8.34 million -1.3%2.4%3.1 $8.56 6/30/2022988,000 shares $8.09 million -12.6%2.8%2.9 $8.19 6/15/20221,130,000 shares $9.53 million -8.1%3.2%3.4 $8.43 5/31/20221,230,000 shares $11.89 million +5.1%3.1%3.7 $9.67 5/15/20221,170,000 shares $11.00 million +10.4%2.9%3.4 $9.40 4/30/20221,060,000 shares $7.67 million +14.3%2.7%3.2 $7.24 4/15/2022927,800 shares $6.73 million +1.8%2.3%3.3 $7.25 3/31/2022911,100 shares $7.23 million -0.8%2.3%2.9 $7.94 3/15/2022918,200 shares $7.46 million -8.1%2.3%2.6 $8.12 2/28/2022998,800 shares $9.33 million +14.7%2.5%2.6 $9.34 2/15/2022870,800 shares $7.39 million -15.5%2.2%2.2 $8.49 1/31/20221,030,000 shares $8.97 million +3.4%2.7%2.7 $8.71 1/15/2022995,800 shares $9.11 million +17.4%2.6%2.6 $9.15 12/31/2021848,100 shares $7.95 million +24.9%2.2%2.3 $9.37 12/15/2021679,000 shares $5.98 million +31.1%1.8%2.3 $8.80 11/30/2021518,000 shares $4.96 million +3.8%1.4%2.4 $9.57 11/15/2021499,200 shares $5.84 million -44.0%1.3%2.6 $11.69 10/29/2021890,800 shares $13.53 million +1.2%2.3%5.5 $15.19 10/15/2021880,000 shares $11.99 million -6.9%2.3%6.3 $13.62 9/30/2021945,100 shares $14.93 million -10.0%2.5%6.8 $15.80 9/15/20211,050,000 shares $17.13 million -7.1%2.8%7.7 $16.31 8/31/20211,130,000 shares $19.28 million -2.6%3.0%7.8 $17.06 8/13/20211,160,000 shares $18.43 million -6.5%3.0%7.3 $15.89 7/30/20211,240,000 shares $25.26 million -8.8%3.3%7.5 $20.37 7/15/20211,360,000 shares $27.24 million +2.3%3.6%6.6 $20.03 6/30/20211,330,000 shares $28.74 million -3.6%3.6%6.1 $21.61Musk’s real agenda in D.C. (Ad)In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…Here’s the full story. 6/15/20211,380,000 shares $27.83 million -4.2%3.7%6.3 $20.17 5/28/20211,440,000 shares $29.23 million +18.0%3.8%6.5 $20.30 5/14/20211,220,000 shares $25.67 million +8.0%3.2%4.8 $21.04 4/30/20211,130,000 shares $21.33 million +10.8%3.0%4.2 $18.88 4/15/20211,020,000 shares $19.81 million +44.1%2.7%4.5 $19.42 3/31/2021708,000 shares $13.54 million -14.6%1.9%2.9 $19.12 3/15/2021829,200 shares $17.01 million +6.0%2.2%3.3 $20.51 2/26/2021782,300 shares $16.84 million -9.2%2.1%3 $21.53 2/12/2021861,600 shares $16.69 million +4.9%2.3%3.6 $19.37 1/29/2021821,100 shares $14.69 million -17.2%2.2%3.9 $17.89 1/15/2021991,500 shares $19.21 million -9.0%2.7%4.1 $19.37 12/31/20201,090,000 shares $19.29 million -0.9%2.9%4.6 $17.70 12/15/20201,100,000 shares $17.58 million +0.9%3.0%4.7 $15.98 11/30/20201,090,000 shares $15.67 million +1.9%3.0%3.9 $14.38 11/15/20201,070,000 shares $15.66 million -4.5%2.9%3.8 $14.64 10/30/20201,120,000 shares $14.26 million +15.6%3.1%4 $12.73 10/15/2020969,100 shares $13.10 million -5.0%2.7%3.5 $13.52 9/30/20201,020,000 shares $11.86 million -11.3%2.8%3.5 $11.63 9/15/20201,150,000 shares $12.36 million -3.4%3.2%2.9 $10.75 8/31/20201,190,000 shares $14.13 million -15.0%3.3%3.1 $11.87 8/14/20201,400,000 shares $16.09 million -7.3%3.9%3.4 $11.49 7/31/20201,510,000 shares $17.17 million -11.7%4.2%3.3 $11.37 7/15/20201,710,000 shares $19.13 million +34.7%4.8%3.3 $11.19 6/30/20201,270,000 shares $11.62 million +3.3%3.5%2.1 $9.15 6/15/20201,230,000 shares $12.08 million +4.2%3.4%2.2 $9.82 5/29/20201,180,000 shares $11.45 million -20.8%3.3%2 $9.70 5/15/20201,490,000 shares $12.19 million -14.4%4.1%2.5 $8.18 4/30/20201,740,000 shares $16.97 million +24.3%4.8%3.1 $9.75 4/15/20201,400,000 shares $10.96 million -14.6%3.9%2.8 $7.83 3/31/20201,640,000 shares $13.69 million +0.9%4.6%3.8 $8.35 AXGN Short Interest - Frequently Asked Questions What is AxoGen's current short interest? Short interest is the volume of AxoGen shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 1,510,000 shares of AXGN short. 3.69% of AxoGen's shares are currently sold short. Learn More on AxoGen's current short interest. What is a good short interest ratio for AxoGen? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AXGN shares currently have a short interest ratio of 3.0. Learn More on AxoGen's short interest ratio. Which institutional investors are shorting AxoGen? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AxoGen: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for AxoGen? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.69% of AxoGen's floating shares are currently sold short. Is AxoGen's short interest increasing or decreasing? AxoGen saw a decline in short interest in March. As of March 15th, there was short interest totaling 1,510,000 shares, a decline of 18.4% from the previous total of 1,850,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does AxoGen's short interest compare to its competitors? 3.69% of AxoGen's shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to AxoGen: PROCEPT BioRobotics Co. (11.24%), Envista Holdings Co. (4.78%), TransMedics Group, Inc. (30.60%), Soleno Therapeutics, Inc. (14.91%), LivaNova PLC (2.86%), Enovis Co. (9.38%), NovoCure Limited (5.49%), Warby Parker Inc. (9.47%), LeMaitre Vascular, Inc. (5.69%), CONMED Co. (9.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short AxoGen stock? Short selling AXGN is an investing strategy that aims to generate trading profit from AxoGen as its price is falling. AXGN shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against AxoGen? A short squeeze for AxoGen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AXGN, which in turn drives the price of the stock up even further. How often is AxoGen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXGN, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies PRCT Short Interest Data NVST Short Interest Data TMDX Short Interest Data SLNO Short Interest Data LIVN Short Interest Data ENOV Short Interest Data NVCR Short Interest Data WRBY Short Interest Data LMAT Short Interest Data CNMD Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AXGN) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AxoGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AxoGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AXGN Stock Free AXGN Stock Alerts